Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate

Summary

The investigators are studying two FDA-approved modalities used to treat overactive bladder to determine if they improve overactive bladder with or without urge incontinence when used together rather than separately, percutaneous tibial nerve stimulation (PTNS) versus PTNS and fesoterodine fumarate.

Timeline

Start

2012-06

Primary completion

2013-03

Completion

2013-03

Outcome

Outcome not reported

Stopped (Enrollment): “Low recruitment rate, and study patients were removed prior to completion”

Drugs

Indications